Clinical Trial Update: Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial results assess the efficacy of T1675 versus placebo in bilateral treated moderate dry eye disease. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• T1675

Snippet

Sponsor: Laboratoires Thea | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED